In vitro transdermal iontophoretic delivery of leuprolide under constant current application

Journal of Controlled Release

Volumn 98, Issue 1, 2004, Pages 25-35

  Kochhar, Charu ^a   Imanidis, Georgios ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Constant current; Iontophoresis; Leuprolide; Polyelectrolyte; Transference number

Indexed keywords

CURRENT DENSITY; DRUG PRODUCTS; ELECTRODES; ELECTROLYTES; ELECTROOSMOSIS; MACROMOLECULES; MEMBRANES; PH EFFECTS;

HEAT SEPARATION; IONIC VALENCE; MACROMOLECULAR ELECTROLYTE;

BIOCHEMICAL ENGINEERING;

BORIC ACID; CITRIC ACID; LEUPRORELIN; PHOSPHATE;

ALKALINITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTRIC RESISTANCE; ELECTRODE; HEAT; HUMAN; HUMAN CELL; HUMAN TISSUE; ION TRANSPORT; IONTOPHORESIS; MACROMOLECULE; MEMBRANE TRANSPORT; PRIORITY JOURNAL; SEPARATION TECHNIQUE;

ADMINISTRATION, CUTANEOUS; DRUG DELIVERY SYSTEMS; HUMANS; IONTOPHORESIS; LEUPROLIDE; SKIN;

EID: 3042813625     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.04.008     Document Type: Article

References (30)

1. Marreo D., Brunette R.R. Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin. J. Pharm. Sci. 75:1986;738-743
2. Stephan R.H., Petelenz T.J., Jacobson S.C. Potential novel methods for insulin administration: I. Iontophoresis. Biomed. Biochem. Acta. 3:1984;553-558
3. Cullander C., Guy G.H. (D) Routes of drug delivery: case studies (6) Transdermal delivery of peptides and proteins. Adv. Drug Del. Rev. 8:1992;291-329
4. Chien Y.W., Siddiqui O., Shi W.-M., Leawongs P., Liu J.C. Direct current iontophoretic transdermal delivery of peptide and protein drugs. J. Pharm. Sci. 78:1989;376-383
5. Sage B.H., Bock C.R., DeNuzzio J.D., Hoke R.H. Technological and developmental issues of iontophoretic transport of peptide and protein drugs. Lee V.H.L., Hashida M., Mizushima Y. Trends And Future Perspectives In Peptide And Protein Drugs. 1995;111-134 Harwood Academic Publishers, Chur, Switzerland
6. Srinivasan V., Higuchi W.I., Sims S.M., Ghanem A.-H., Behl C.R. Transdermal iontophoretic drug delivery: mechanistic analysis and applications to polypeptide delivery. J. Pharm. Sci. 78:1989;370-375
7. Kuret J.A., Murad F. Adenohypophyseal hormones and related substances. Goodman Gilman A., Rall T.W., Nies A.S., Taylor P. The Pharmacological Basis of Therapeutics. 1992;1335-1360 McGraw-Hill, Singapore
8. Saunders L.M., Kent J.S., McRae G.I., Vickery B.H., Tice T.R., Lewis D.H. Controlled release of a leuteinising hormone releasing hormone analogue from (D, L-lactide, glycolide) microspheres. J. Pharm. Sci. 73:1984;1294
9. Okada H., Toghuchi H. Biodegradable microspheres in drug delivery. Clin. Rev. Ther. Drug Syst. 12:1995;1-99
10. Ravivarapu H.B., Moyer K.L., Dunn R.L. Parameters affecting the efficacy of a sustained release polymeric implant of Leuprolide. Int. J. Pharm. 194:2000;181-191
11. Qiu Y., Johnson H.W., Reiland T.L., Lu M.Y.F. Sublingual absorption of Leuprolide: comparison between human and animal models. Int. J. Pharm. 179:1999;27-36
12. Adjei A., Sundberg D., Miller D., Chun A. Bioavailability of Leuprolide acetate following nasal and inhalation delivery to rats and healthy humans. Pharm. Res. 9:1992;244-249
13. Lu M.F., Lee D., Carlson R., Rao G.S., Hui H.W., Adjei L., Herrin M., Sundberg D., Hsu L. The effects of formulation variables on iontophoretic transdermal delivery of Leuprolide to humans. Drug Dev. Ind. Pharm. 19:1993;1557-1571
14. Meyer B.R., Kreis W., Eschbach J., O'Mara V., Rosen S., Sibalis D. Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers. Clin. Pharmacol. Ther. 44:1988;607-612
15. Kochhar C., Imanidis G. In vitro transdermal iontophoretic delivery of Leuprolide - mechanisms under constant voltage application. J. Pharm. Sci. 92:2003;84-96
16. Banga A.K., Chien Y.W. Iontophoretic delivery of drugs: fundamentals, developments and biomedical applications. J. Control. Release. 7:1988;1-24
17. Phipps J.B., Gyory J.R. Transdermal ion migration. Adv. Drug Del. Rev. 9:1992;137-176
18. Atkins P.W. Physical Chemistry. 3rd edition:1986;663-686 Freeman and Co. New York
19. Oh S.Y., Guy R.H. Effects of iontophoresis on the electrical properties of human skin in-vivo. Int. J. Pharm. 124:1995;137-142
20. Hoogstraate A.J., Srinivasan V., Sims S.M., Higuchi W.I. Iontophoretic enhancement of peptides: behaviour of Leuprolide versus model permeants. J. Control. Release. 31:1994;41-47
21. Burnette R.R., Ongpipattanakul B. Characterization of the permselective properties of excised human skin during iontophoresis. J. Pharm. Sci. 76:1987;765-773
22. Marro D., Kalia Y.N., Delgado-Charro M.B., Guy R.H. Optimizing iontophoretic drug delivery: identification and distribution of the charge-carrying species. Pharm. Res. 18:2001;1709-1713
23. C. Kochhar, Iontophoretic delivery of Leuprolide: Constant voltage and constant current effects, PhD thesis, University of Basel, 2001.
24. Manning G.S. Limiting laws and counter-ion condensation in polyelectrolyte solutions: I. Colligative properties. J. Chem. Phys. 51:1969;924-933
25. Manning G.S. Molecular theory of polyelectrolyte solutions with applications to the electrostatic properties of polynucleotides. Q. Rev. Biophys. 11:1978;179-246
26. Klein J.W., Ware B.R. Direct observation of the transition to the counter-ion condensation. J. Chem. Phys. 80:1984;1334-1339
27. Li S.K., Ghanem A.-H., Peck K.D., Higuchi W.I. Iontophoretic transport across a synthetic membrane and human epidermal membrane: a study of the effects of permeant charge. J. Pharm. Sci. 86:1997;680-689
28. Sennello L.T., Finley R.A., Chu S.Y., Jagst C., Max D., Rollins D.E., Tolman K.G. Single dose pharmacokinetics of Leuprolide in humans following intravenous and subcutaneous administration. J. Pharm. Sci. 75:1986;158-160
29. Singh J., Bhatia K. Topical iontophoretic drug delivery: pathways, principles, factors and skin irritation. Med. Res. Rev. 16:1996;285-296
30. Luzardo-Alvarez A., Delgado-Charro M.B., Blanco-Mendez J. Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation. Pharm. Res. 18:2001;1714-1720